These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24097913)

  • 21. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
    Cazzola M; Noschese P; De Michele F; D'Amato G; Matera MG
    Respir Med; 2006 Feb; 100(2):212-7. PubMed ID: 15936184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
    N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC; Martin P; Mezzanotte WS
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
    Szmidt M
    Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
    Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
    Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of budesonide/formeterol combination therapy in asthma patients.
    Jakopović M; Pavicić F; Redzepi G; Plestina S; Janković M; Franić Z; Samija M; Samarzija M
    Coll Antropol; 2009 Jun; 33(2):587-91. PubMed ID: 19662783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy for chronic obstructive pulmonary disease: clinical aspects.
    Donohue JF
    Proc Am Thorac Soc; 2005; 2(4):272-81; discussion 290-1. PubMed ID: 16267348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.
    Bergeron A; Belle A; Chevret S; Ribaud P; Devergie A; Esperou H; Ades L; Gluckman E; Socié G; Tazi A
    Bone Marrow Transplant; 2007 May; 39(9):547-53. PubMed ID: 17351647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budesonide and risk of pneumonia.
    Black PN; Sexton PM
    Lancet; 2009 Dec; 374(9707):2050-2051. PubMed ID: 20109825
    [No Abstract]   [Full Text] [Related]  

  • 36. The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia.
    Rennard SI; Sin DD; Tashkin DP; Calverley PM; Radner F
    Ann Am Thorac Soc; 2015 Oct; 12(10):1587-9. PubMed ID: 26448356
    [No Abstract]   [Full Text] [Related]  

  • 37. [A pharmacovigilance study in chest diseases outpatient clinic].
    Usta C; Cilli A; Celenk B; Uzun R
    Tuberk Toraks; 2012; 60(2):123-8. PubMed ID: 22779932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [2 step inhaler for twice daily use].
    Einecke D
    MMW Fortschr Med; 2015 Mar; 157(4):68. PubMed ID: 25743988
    [No Abstract]   [Full Text] [Related]  

  • 39. Budesonide and risk of pneumonia.
    Singanayagam A; Chalmers JD
    Lancet; 2009 Dec; 374(9707):2050. PubMed ID: 20109824
    [No Abstract]   [Full Text] [Related]  

  • 40. [A vulnerable elderly man with prednisone-induced delirium].
    Otten RI; Jansen IHM; Zeeman M
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.